Maddalena Adorno, Ph.D, Chief Executive Officer

Dr. Adorno holds a M.Sc. in Medical Biotechnology and a Ph.D in Biomedicine and Cancer Biology. She did her post-doctoral research at Stanford School of Medicine and worked there as Research Fellow until 2018. She has fifteen years of experience in cancer biology, stem cells, and aging. She has publications in Nature, Cell, and Science and she is an inventor on several international patents.

Benedetta di Robilant, Ph.D, Chief Scientific Officer

Dr. di Robilant obtained her PhD in basic and applied immunotherapy at San Raffaele University in Milan, where she became an expert in CAR-T cells and antigen validation. She worked as a postdoctoral fellow at Stanford University Medical School until 2018 where she focused on aging, senescence and stem cell self-renewal.


Hazal Pektaz, M.S., Research Associate

Master of Science at UCSF

Michelle Arkin, Ph.D., Consultant

Associate Professor in Pharmaceutical Chemistry at UCSF

Co-director of the SMDC at USCF

Johanna Theruvath, MD, Ph.D, Consultant

Post-Doctoral Fellow at Stanford University